Toviaz is a Oral Tablet, Film Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Fesoterodine Fumarate.
Product ID | 0069-0244_2d81c85f-b447-43c4-94f4-c69ec06a965a |
NDC | 0069-0244 |
Product Type | Human Prescription Drug |
Proprietary Name | Toviaz |
Generic Name | Fesoterodine Fumarate |
Dosage Form | Tablet, Film Coated, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2008-10-31 |
Marketing Category | NDA / NDA |
Application Number | NDA022030 |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | FESOTERODINE FUMARATE |
Active Ingredient Strength | 8 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2008-10-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022030 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-10-31 |
Marketing End Date | 2014-02-03 |
Marketing Category | NDA |
Application Number | NDA022030 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2008-10-31 |
Marketing End Date | 2014-02-03 |
Marketing Category | NDA |
Application Number | NDA022030 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2008-10-31 |
Ingredient | Strength |
---|---|
FESOTERODINE FUMARATE | 8 mg/1 |
SPL SET ID: | 5be745f0-8ae7-4c3c-9962-37d6263326f1 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0069-0242 | Toviaz | fesoterodine fumarate |
0069-0244 | Toviaz | fesoterodine fumarate |
55154-2737 | Toviaz | fesoterodine fumarate |
55154-2738 | Toviaz | fesoterodine fumarate |
63539-183 | Toviaz | fesoterodine fumarate |
63539-242 | Toviaz | fesoterodine fumarate |
69189-0244 | Toviaz | Toviaz |
69189-0242 | Toviaz | Toviaz |
43598-247 | Fesoterodine fumarate | Fesoterodine fumarate |
43598-248 | Fesoterodine fumarate | Fesoterodine fumarate |
51407-661 | Fesoterodine fumarate | Fesoterodine fumarate |
51407-662 | Fesoterodine fumarate | Fesoterodine fumarate |
62332-175 | Fesoterodine Fumarate | Fesoterodine Fumarate |
62332-176 | Fesoterodine Fumarate | Fesoterodine Fumarate |
62559-376 | Fesoterodine Fumarate | Fesoterodine Fumarate |
65162-369 | Fesoterodine Fumarate | Fesoterodine Fumarate |
65162-370 | Fesoterodine Fumarate | Fesoterodine Fumarate |
65862-766 | FESOTERODINE FUMARATE | FESOTERODINE FUMARATE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TOVIAZ 78775360 3610405 Live/Registered |
C.P. PHARMACEUTICALS INTERNATIONAL C.V. 2005-12-16 |
TOVIAZ 78170585 3083382 Dead/Cancelled |
C.P. PHARMACEUTICALS INTERNATIONAL C.V. 2002-10-03 |
TOVIAZ 77231732 not registered Dead/Abandoned |
Pfizer Inc. 2007-07-17 |
TOVIAZ 77180116 not registered Dead/Abandoned |
Pfizer Inc. 2007-05-14 |